Abstract
Obesity increases the risk of morbidity and mortality and reduces quality of life independent of age, sex or ethnicity. Leading health authorities recommend weight loss as a primary treatment strategy for obesity reduction--weight loss goals range from 5% to 10% of initial body weight. Intentional weight loss in most adults is associated with a reduction in many of the health complications of obesity. Nonetheless, emerging evidence supports the notion that a lifestyle-modification program characterized by an increase in physical activity and a balanced diet can reduce obesity and the risk of obesity-related comorbid conditions despite minimal or no weight loss. The benefits of such an approach include appreciable reductions in abdominal obesity, visceral fat and cardiometabolic risk factors, and increases in both skeletal muscle mass and cardiorespiratory fitness. Individuals with obesity face a serious challenge if they are to attain even modest weight loss in today's obesogenic environment. Clinicians could encourage positive lifestyle changes in their patients by counseling them that obesity and its associated health risks can be reduced in response to an increase in physical activity with or without weight loss.
Keywords
Weight lossMedicineObesityCardiorespiratory fitnessSarcopenic obesityPhysical therapyGerontologyEnvironmental healthInternal medicine
MeSH Terms
Anti-Obesity AgentsExerciseHumansObesityRisk FactorsWeight Loss
Affiliated Institutions
Related Publications
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Obesity is associated with numerous short- and long-term health consequences. Low levels of physical activity and poor dietary habits are consistent with an increased risk of ob...
Once-Weekly Semaglutide in Adults with Overweight or Obesity
In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body we...
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
Abstract Non‐alcoholic steatohepatitis (NASH), is a critical link in the chain of metabolic fatty liver disorders that spans steatosis to cryptogenic cirrhosis. It is the hepati...
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based ...
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
In Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, ther...
Publication Info
- Year
- 2009
- Type
- review
- Volume
- 5
- Issue
- 6
- Pages
- 319-325
- Citations
- 242
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
242
OpenAlex
9
Influential
180
CrossRef
Cite This
Robert Ross,
Alison Bradshaw
(2009).
The future of obesity reduction: beyond weight loss.
Nature Reviews Endocrinology
, 5
(6)
, 319-325.
https://doi.org/10.1038/nrendo.2009.78
Identifiers
- DOI
- 10.1038/nrendo.2009.78
- PMID
- 19421242